Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicover ABLTS:0RPS +0.62%87 Earnings per Share (Diluted) is kr6.11 as of Jun. 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 87/100 and a GF Value™ of kr233.19 (Fairly Valued). The stock has 6 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Medicover AB ranks better than 93.24% on this metric.
Medicover AB's EPS (Basic) for the
three
months ended in Jun. 2026 was kr1.77.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was kr6.12.
Medicover AB's EPS without NRI for the
three
months ended in Jun. 2026 was kr1.77.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was kr6.11.
During the past 12 months, Medicover AB's average EPS without NRIGrowth Rate was 91.90% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 70.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 3.80% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 18.10% per year.
During the past 12 years, Medicover AB's highest 3-Year average EPS without NRI Growth Rate was 84.20% per year. The lowest was -32.10% per year. And the median was 38.10% per year.
Medicover AB (LTS:0RPS) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medicover AB Earnings per Share (Diluted) Related Terms
Medicover AB Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Medicover AB's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RPS vs HCA, THC, EHC: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Medicover AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicover AB PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's PE Ratio distribution charts can be found below:
* The bar in red indicates where Medicover AB's PE Ratio falls into.
Medicover AB Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Medicover AB's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of kr6.11 mean?
Medicover AB (LTS:0RPS) has a Earnings per Share (Diluted) of kr6.11 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medicover AB and its competitors. According to the industry distribution chart, Medicover AB ranks #34 out of 503 companies in the Healthcare Providers & Services industry, placing it in the top 6.8%.
Is Medicover AB's Earnings per Share (Diluted) too high?
Medicover AB's current Earnings per Share (Diluted) is kr6.11. Based on the distribution chart, Medicover AB ranks #34 out of 503 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medicover AB has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #34 out of 503 companies for Earnings per Share (Diluted). This places Medicover AB in the top 7% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Earnings per Share (Diluted) is kr6.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.19, compared to a current price of kr243.50 — trading 4.4% above its estimated fair value. The current Earnings per Share (Diluted) is kr6.11. Medicover AB's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Earnings per Share (Diluted) is kr6.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (LTS:0RPS) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued.
The current stock price of kr243.50 is trading 4.4% above its estimated GF Value™ of kr233.19.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for LTS:0RPS:
Earnings per Share (Diluted): kr6.11
GF Value™: kr233.19 vs. price of kr243.50 (4.4% above fair value)
No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
87GF Score
Get the complete analysis for LTS:0RPS
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RPS has been successfully added to your 
